Elravie Premier Deep Line LC — HI Technology HA Filler for Moderate-to-Deep Wrinkles (1ml)

Elravie Premier Deep Line LC is Humedix’s mid-density monophasic HA filler — 23 mg/mL cross-linked HA + 0.3% lidocaine using patented HI Technology and TFF UF (Tangential Flow Filtration Ultra Filtration) purification. HA purity above 99.5%, endotoxin under 0.05 EU/mL. Engineered for mid-to-deep dermal placement targeting nasolabial folds, marionette lines, and lip augmentation. Up to 18 months durability with single re-touch.

Elravie Premier Deep Line LC Filler is manufactured by Humedix Co. Ltd., a South Korea-based medical device and pharmaceutical company established in 2003. The product is part of the Elravie Premier dermal filler range, which is distributed across multiple international markets. Regulatory status: KFDA registered · CE marked · GMP certified · ISO.

Elravie Premier Deep Line LC Filler contains 23 mg/mL of cross-linked hyaluronic acid plus 0.3% (3 mg/mL) premixed lidocaine for injection comfort. The hyaluronic acid is non-animal, produced by bacterial fermentation and cross-linked using Humedix Co. Ltd.’s HI (High molecular Ideal Reticulated Matrix) Technology technology. Phosphate-buffered saline at near-physiological pH carries the gel.

Per Humedix Co. Ltd.’s clinical data, Elravie Premier Deep Line LC Filler delivers 9-18 months of correction depending on placement and patient factors. Duration depends on injection depth, dose, anatomical site, patient metabolism, and facial movement intensity. Mid-deep dermis placement typically delivers the longer end of the duration range.

Elravie Premier Deep Line LC Filler is engineered for mid-deep dermis placement. The standard recommended needle is 27G, supplied in the syringe blister pack. Some practitioners prefer a blunt-tip cannula of equivalent gauge for safer placement in highly vascular zones, particularly for deeper subcutaneous work.

Elravie Premier Deep Line LC Filler regulatory status: KFDA registered · CE marked · GMP certified · ISO. The product’s KFDA registration in South Korea is the primary regulatory baseline. CE marking and other international approvals enable distribution in the EU and other regulated markets. US FDA status varies — buyers in regulated jurisdictions should verify approval scope before importation and clinical use.

Store Elravie Premier Deep Line LC Filler between 2 °C and 25 °C in original packaging, away from direct sunlight. Do not freeze — freezing damages the HA gel structure. Shelf life is typically 24 months from the manufacturing date printed on the box when unopened. Once a syringe is opened, contents must be used immediately. Partial syringes cannot be retained for later use due to sterility risk.

No. Elravie Premier Deep Line LC Filler uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products. The product is contraindicated in patients with severe allergies to gram-positive bacterial proteins (used in HA fermentation).

Yes — layered protocols combining different fillers are standard aesthetic practice. Elravie Premier Deep Line LC Filler can be combined with other Korean or international HA fillers, neuromodulators (botulinum toxin), or biostimulators (PLLA, calcium hydroxylapatite) within a single session. Always wait the recommended interval between different injectable products and confirm biocompatibility per each manufacturer’s IFU.

Per Humedix clinical data, Elravie Premier Deep Line LC delivers 9-12 months of correction following the initial injection, with documented extension to 18 months when a single re-touch session is performed at the 9-12 month mark. The extended durability reflects the HI Technology cross-linked matrix’s high resistance to external force and minimal migration. Individual duration depends on injection depth, dose, anatomical site, and facial movement intensity.